Ion Exchange India FY26 Annual Report: Profit Declines Amidst New Plant Costs

Ion Exchange India's standalone net profit for the financial year 2025-26 fell by 35.5% to Rs 138.38 crore, compared to Rs 214.48 crore in FY 2024-25. Consolidated net profit also saw a decrease to Rs 143.20 crore from Rs 208.25 crore.

Revenue from operations showed growth, with standalone revenue rising 5.5% to Rs 2,678.91 crore from Rs 2,540.06 crore. Consolidated revenue increased to Rs 2,914.84 crore from Rs 2,737.11 crore.

Reader Takeaway: Higher costs from the new Roha plant pressure profits, while topline growth continues.

What just happened

The company released its Annual Report for FY2025-26, detailing a significant drop in net profit despite revenue growth. This decline is primarily due to increased interest and depreciation costs associated with the newly commissioned resin manufacturing plant at Roha, Maharashtra. Higher raw material costs and the impact of new labor legislation also contributed to the reduced profitability.

Why this matters

Investors will be watching how the company manages the increased operating expenses from the Roha facility. While the topline is showing resilience with a 5.5% increase in standalone revenue, the bottom line has been impacted. The board has recommended a final dividend of Rs 1.25 per share, a decrease from Rs 1.50 per share in the previous year, reflecting the current financial pressures.

The backstory

The phased commissioning of the new resin manufacturing plant at Roha began on September 30, 2025. This expansion is a key strategic move for Ion Exchange, aiming to significantly increase its production capacity. The initial phase has a capacity of 3,696 cubic meters/year, with a long-term goal of reaching 42,600 cubic meters/year.

What changes now

The company is in a transition phase, absorbing costs related to its new manufacturing unit. Shareholders will need to track the ramp-up of the Roha plant and the company's ability to achieve economies of scale and pass on cost increases. The focus remains on long-term growth, particularly in emerging sectors like semiconductors and green hydrogen.

Risks to watch

Key risks include the successful operationalization and cost management of the new Roha plant, volatile raw material prices, and the impact of evolving labor regulations. The ability to secure new orders and maintain profitability in competitive segments like Engineering and Home Water will be crucial.

Peer comparison

While specific peer financial data for the same period isn't provided in the filing, Ion Exchange operates in the water treatment and related engineering solutions space, facing competition from domestic and international players. Companies in this sector often navigate similar challenges of capital expenditure for expansion and raw material cost fluctuations.

Context metrics (time-bound)

• FY 2025-26 Standalone Revenue: Rs 2,678.91 crore
• FY 2025-26 Standalone PAT: Rs 138.38 crore
• FY 2024-25 Standalone Revenue: Rs 2,540.06 crore
• FY 2024-25 Standalone PAT: Rs 214.48 crore
• Roha plant commissioning started: September 30, 2025
• Recommended final dividend: Rs 1.25 per share

What to track next

Investors should closely monitor the progress of the Roha plant's capacity utilization and its contribution to the company's financial performance in the coming quarters. The company's strategy for growth in new sectors and its ability to manage costs will be key factors to watch.